AEterna Zentaris Inc. Stock Nasdaq
Equities
CA0079753038
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | 5.64M | Sales 2023 | 4.5M | Capitalization | 9.41M |
---|---|---|---|---|---|
Net income 2022 | -22M | Net income 2023 | -16M | EV / Sales 2022 | -6.21 x |
Net cash position 2022 | 50.43M | Net cash position 2023 | 33.74M | EV / Sales 2023 | -5.41 x |
P/E ratio 2022 |
-0.68
x | P/E ratio 2023 |
-0.57
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.41% |
Latest transcript on AEterna Zentaris Inc.
Managers | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 98-12-31 |
Director of Finance/CFO | - | 22-01-23 | |
Patricia Zahn
ADM | Chief Administrative Officer | - | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 19-12-31 |
Peter Edwards
BRD | Director/Board Member | 62 | 20-05-14 |
Dennis Turpin
BRD | Director/Board Member | - | 21-05-04 |
1st Jan change | Capi. | |
---|---|---|
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-12.29% | 10.65B |